Skip to main content

View full-text article in PMC

. 2010 Aug;60(4):272–281.

Table 1.

Chrm2 genotype and phenotype strain distribution patterns

				Responses at 30 min after injection of 0.1 mg.kg oxotremorine
Strain	Chrm2 genotype^a	Startle amplitude^b	PPI^c	Hypothermia (°C)	Tremor^d	Salivation^d	Bradycardia (bpm)^d
BALB/cByJ	BALB/cByJ	high	impaired	−4.4 ± 0.4	1.5 ± 0.2	1.5 ± 0.2	−98 ± 22
C57BL/6J	C57BL/6J	low	normal	−4.0 ± 0.6	1.8 ± 0.2	1.2 ± 0.3	−151 ± 39
CXB2	C57BL/6J	not tested	not tested	−6.3 ± 0.5	1.8 ± 0.2	1.8 ± 0.2	−86 ± 69
CXB3	BALB/cByJ	low	impaired	−5.1 ± 0.6	2.0 ± 04	0.8 ± 0.2	−190 ± 22
CXB5	BALB/cByJ	not tested	not tested	−3.7 ± 0.6	2.0 ± 0.3	1,4 ± 0.4	−157 ± 21
CXB6	BALB/cByJ	high	normal	−4.5 ± 0.4	1.9 ± 0.1	1.3 ± 0.2	−221 ± 44
CXB9	BALB/cByJ	low	impaired	−6.5 ± 0.5	0.7 ± 0.2	0.6 ± 0.2	−38 ± 23
CXB12	C57BL/6J	high	impaired	−4.9 ± 0.7	1.8 ± 0.2	0.3 ± 0.2	−81 ± 15

^a

Data from Figure 1

^b

Data from Figures 4,5; relative amplitudes

^c

Data from Figures 4,5 (10 dB)

^d

Data from Figures 2,3